Advertisement

Water, Amoebiasis and Public Health

  • Prati Pal SinghEmail author
  • Abhiruchi Galhotra
Chapter

Abstract

Human amoebiasis causes highest number of deaths due to any parasitic disease after malaria and schistosomiasis. Entamoeba histolytica/Entamoeba dispar, the causative parasites, exist in two forms: the highly active and invasive trophozoites and the infective cysts. The disease is transmitted by faecal-oral rout, oral-rectal contamination and by the ingestion of infective cysts in drinking water and food etc. Metronidazole, the most commonly used drug for the treatment of symptomatic amoebiasis, is fraught with several problems including emergence of resistance by E. histolytica. The prevention of the disease through improved sanitation and drinking water quality are some of the most effective means to control the disease. Additionally, the role(s) of mothers, proper hand washing and maintenance of good personal hygiene are also important in the containment of the disease.

Keywords

Cysts Drinking water Entamoeba histolytica/E. dispar Hand washing Metronidazole Sanitation 

References

  1. Abramowicz M (2002) Drugs for parasitic infections. Med Lett Drug Ther 44:1–12Google Scholar
  2. Brumpt E (1925) Etude sominaire de 1 “Entamoeba dispar” n sp Amibe a kystes quadrinuclees, parasite de l’homme. Bull Acad Med (Paris) 94:943–952Google Scholar
  3. Budd G (1857) On diseases of the liver. Churchill, LondonGoogle Scholar
  4. Chatterjee KD (2011) Parasitology, 13th edn. CBS Publishers, New Delhi, pp 18–41Google Scholar
  5. Clark CG (1998) Amoebic disease: Entamoeba dispar, an organism reborn. Trans R Soc Trop Med Hyg 92:361–364CrossRefGoogle Scholar
  6. Cox FEG (2002) History of human parasitology. Clin Microbiol Rev 15:595–612CrossRefGoogle Scholar
  7. Cunningham DD (1871) A report on cholera. In: 7th annual report sanitation communications, India 1869, Appendix B, pp 141–234Google Scholar
  8. Di Perri G, Strosselli M, Rondanelli EG (1989) Therapy of entamoebiasis. J Chemother 1:113–122Google Scholar
  9. Diamond LS, Clark CG (1993) A redescription of Entamoeba histolytica Scahudin, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryote Microbiol 40:340–344CrossRefGoogle Scholar
  10. Eichinger D (1997) Encystation of entamoeba parasites. Biol Essays 19:633–639Google Scholar
  11. Ejemot-Nwadiaro RI, Ehiri JE, Meremikwu MM, Critchley JA (2012) Hand washing for preventing diarrhoea (Review), vol 2. The Cochrane Library, Wiley, New YorkGoogle Scholar
  12. Gatti S, Swierczynski G, Robinson F, Anselmi M, Corrales J, Moreira J et al (2002) Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador. Am J Trop Med Hyg 67:123–127Google Scholar
  13. Gilbert DN, Moellering RC, Jr. Sande MA (eds) (2002) Treatment of parasitic infections. In: The sanford guide to antimicrobial therapy, 32 edn. Antimicrobial Therapy Inc., Hyde Park, pp 90–98Google Scholar
  14. Goodman A, Rall TW, Niess AS, Taylor P (1992) The pharmacologic basis of therapeutics, 8th edn. Pregamon Press Inc, New York, p 1002Google Scholar
  15. Kartulis S (1886) Zur Aetiologie der Dysenterie in Aegypten. Virchows Archieves fur Pathologie und Anatomie 105:521CrossRefGoogle Scholar
  16. Kartulis S (1887) Zur Aetiologie der Leberabscesse: lebende Dysenterie–Amoeben in Eiter der dysenterischen Leberabscesse. Zentralbl fur Bakt 1:745Google Scholar
  17. Kartulis S (1891) Einiges uber die Pathogenese der Desenterieamoben. Zentralbl. fur Bakt. (Abt 1), 9:365Google Scholar
  18. Lewis TR (1870) A report on the microscopic objects found in cholera evaluations. In: 6th annual report sanitation communications, India 1869, Appendix A, pp 125–178Google Scholar
  19. Li E, Stanley SL Jr (1996) Protozoa: Amebiasis—in parasitic diseases of the liver and intestines. Gastroenterol Clin North Am 25:471–492CrossRefGoogle Scholar
  20. Markell EK (1986) The 1933 Chicago outbreak of amoebiasis. West J Med 144:750Google Scholar
  21. Martinez-Palomo A, Espinosa-Cantellano M (1998) Intestinal amoebae. In: Cox FEG, Kreier JP, Wakeline D (eds) Topley and Wilson’s microbiology and microbial infections, vol 5, 9th edn, pp 157–177Google Scholar
  22. Meleny HE, Bishop EL, Leathers WS (1932) Investigations of E. histolytica and other intestinal protozoa in Tennessee. Am J Hyg 16:253Google Scholar
  23. Park K (2011) Park’s textbook of social and preventive medicine, 21st edn. Bhanot Publishers, JabalpurGoogle Scholar
  24. Powell SJ, Macleod L, Wilmot AJ, Elsdon-Dew R (1966) Metronidazole in amoebic dysentery and amoebic liver abscess. Lancet 2:1329–1331CrossRefGoogle Scholar
  25. Quincke HI, Roos E (1893) Ueber Amoben-Enteritis. Wien Med Wochschr 30:1089–1094Google Scholar
  26. Qureshi H, Ali A, Baquai R, Ahmed W (1997) Efficacy of a combined diloxanide-furoate-metronidazole preparation in the treatment of amoebiasis and giardiasis. J Intern Med Res 25:167–170Google Scholar
  27. Rivera WL, Tachibana H, Kanbara H (1998) Field study on the distribution of Entamoeba histolytica and Entamoeba dispar in the northern Philippines as detected by the polymerase chain reaction. Am J Trop Med Hyg 59:916–921Google Scholar
  28. Schaudinn F (1903) Untersuchungen uber die Fortpflanzung einiger Rizhopoden. Arb Keiserl Gesundh Amte 19:547Google Scholar
  29. Seeto RK (1999) Amoebic liver abscess: epidemiology, clinical features and outcome. West J Med 170:104–109Google Scholar
  30. Seulveda B, Trevino-Garcia MN (1986) Clinical manifestations and diagnosis of amoebiasis. In: Martinez-Palomo A (ed) Amoebiasis. Elsevier, Amsterdam, pp 169–188Google Scholar
  31. Stauffer W (2008) Amoebiasis and amebic meningoencephalitis. In: Wallace Robert B (ed) Public health and preventive medicine, 15th edn. McGraw Hill, USAGoogle Scholar
  32. Walsh JA (1984) Estimating the burden of illness in the Tropics. In: Warren KS, Mahmoud AAF (eds) Tropical and geographical medicine. McGraw-Hill, New York, pp 1073–1085Google Scholar
  33. Walsh JA (1986) Problems in recognition and diagnosis of amoebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 8:228–238CrossRefGoogle Scholar
  34. Walsh JA (1988) Prevalence of Entamoeba histolytica infection. In: Ravdin JI (ed) Amebiasis: human infection by Entamoeba histolytica. Wiley, New York, pp 93–105Google Scholar
  35. Wertheim HFL, Horby P, Woodall JP (eds) (2012) Atlas of human infectious diseases. Blackwell Publishing Ltd, First EditionGoogle Scholar
  36. WHO Scientific Working Group (1980) Parasite related diarrhoeas. Bull World Health Organ 58:819–830 WHO, Geneva, SwitzerlandGoogle Scholar
  37. World Health Organization (1969) Amoebiasis: report of a WHO expert committee. WHO technical report series 421, pp 1–52. WHO, Geneva, SwitzerlandGoogle Scholar
  38. World Health Organization (1997) WHO/PAHO/UNESCO report: a consultation with experts on amoebiasis. Mexico City, Mexico. 28–29 Jan 1997. WHO, Geneva, SwitzerlandGoogle Scholar
  39. World Health Organization (1998) Life in the 21st Century: a vision for all. The world health report 1998. World Health Organization, Geneva, SwitzerlandGoogle Scholar

Copyright information

© Springer India 2014

Authors and Affiliations

  1. 1.Centre of Infectious Diseases, Department of Pharmacology and ToxicologyNational Institute of Pharmaceutical Education and ResearchPunjabIndia
  2. 2.Department of Community and Family MedicineAll India Institute of Medical SciencesRaipurIndia

Personalised recommendations